Business Context and Reporting Period
This Form 8-K was filed by Inpixon (noted as XTI Aerospace, Inc. in metadata) on April 20, 2018. The filing reports the entry into a Material Definitive Agreement and amendments to the Company's Articles of Incorporation regarding a new public equity offering.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $10.1 million expected from the sale of 10,115 Units.
- Net Proceeds: Approximately $9.2 million after deducting placement agent fees and expenses.
- Placement Agent Fee: Up to 8.0% of aggregate gross proceeds plus reimbursement of out-of-pocket expenses up to $100,000.
- Use of Proceeds: Working capital, general corporate purposes (R&D, sales, marketing), paying trade payables, and potential future acquisitions or investments.
- Capital Structure Impact: Issuance of 10,115 shares of Series 4 Convertible Preferred Stock and associated Warrants.
Material Changes and Transaction Structure
The Company entered into a Placement Agency Agreement with Roth Capital Partners, LLC to sell Units at $1,000 per Unit. Each Unit consists of:
- Series 4 Preferred Stock: Stated value of $1,000, initially convertible into approximately 2,174 shares of Common Stock (conversion price $0.46). Total issuance converts to approximately 21,989,160 shares of Common Stock.
- Warrants: Immediately exercisable at $0.67 per share to purchase an equivalent number of shares as the Preferred Stock converts into.
The Series 4 Preferred includes anti-dilution protection and a conversion price reset mechanism on the 60th day following issuance, subject to a floor of $0.124. The Warrants also include a price reset feature if the Company issues stock below the exercise price, subject to the same $0.124 floor.
Guidance, Outlook, and Risks
Outlook: The Company expects the Offering to close on or about April 24, 2018, subject to customary conditions. Management intends to use proceeds to support growth strategies, including potential acquisitions, though no current commitments exist.
Risks and Contingencies:
- Dilution: Significant dilution to existing shareholders due to the issuance of convertible preferred stock and warrants.
- Forward-Looking Statements: The filing contains forward-looking statements regarding the Offering and use of proceeds which are subject to risks and uncertainties.
- Lock-Up: Officers, directors, and greater than 5% beneficial owners are subject to a 180-day lock-up agreement.
Financial Metrics: This filing does not provide revenue, profit, cash flow, or margin data for the reporting period.
Investor Verification Checklist
- Verify the final closing date of the Offering (expected April 24, 2018) and actual net proceeds received.
- Review the Certificate of Designation (Exhibit 3.1) for specific terms regarding the anti-dilution floor and conversion price reset mechanics.
- Monitor the impact of the ~22 million new shares of Common Stock (upon conversion) on existing shareholder ownership percentages.
- Confirm the utilization of proceeds for trade payables and R&D as stated in the filing.